
The PharmTech AI Pulse Check panel discusses why MHRA and FDA oversight of pharma AI continues past go-live, and who validates the regulators' own AI.
Once APIs move into later phases of development, an advanced impurity control strategy is vital and demands a comprehensive analytical methods approach.






